Archive | National

AstraZeneca rejects $119 billion offer from Pfizer

LONDON (AP) — The board of AstraZeneca on Monday rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that caused a sharp slide in the U.K. company’s share price as many investors think it effectively brings an end to the protracted and increasingly bitter takeover saga….

Continue Reading 0

AstraZeneca board rejects new offer from Pfizer

LONDON (AP) — The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has caused a sharp slide in the U.K. company’s share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga….

Continue Reading 0